Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Cancer. 2017 May 9;123(17):3261–3268. doi: 10.1002/cncr.30745

Figure 2. Somatic mutational status of 22 genes-of-interest, and the MSI status, in the discovery and prevalence screen CCECs.

Figure 2

(*) indicates four tumors with heterogeneous histology for which the CCEC component was sequenced. Genes and somatic mutation frequencies (% cases mutated) are shown. Somatic mutations (yellow) and MSI (gray) are indicated. (#) denotes genes for which a subset of cases (≤23 tumors) was previously analyzed for mutations and MSI as reported elsewhere 7, 15, 16, 27.